U.S. Obstetrician-Gynecologists Set Their Own Pregnancy Vaccination Schedule, as Professional Guidance and Federal Policy Part Ways

Vaccination during pregnancy involves not only the risks faced by pregnant people themselves, but also the fragile window in the months after birth when newborns have not yet developed immunity. The American College of Obstetricians and Gynecologists (ACOG) has issued its first formal maternal vaccination schedule at a moment when medical judgment and political signals are becoming increasingly difficult to separate, laying out a clearer path for clinicians and pregnant families.

The schedule recommends that most pregnant people receive influenza, COVID-19, Tdap (tetanus, diphtheria, and pertussis), and respiratory syncytial virus (RSV) vaccines during pregnancy; some people with comorbidities, exposure risks, or special circumstances may need evaluation for other vaccines. ACOG has previously supported the use of these vaccines during pregnancy individually, but this time it has integrated them into an official schedule, signaling that the professional organization is no longer merely echoing the federal framework, but offering an independent version that can be used directly in clinical settings.

The sensitivity of the development lies in the marked shift in U.S. federal vaccine policy in recent years. According to reports, during the Trump administration, the department led by Health and Human Services Secretary Robert F. Kennedy Jr. removed some recommendations for influenza and COVID-19 vaccination in pregnant people; the advisory structure that had provided vaccine recommendations to the Centers for Disease Control and Prevention (CDC) has also come under question because of personnel and procedural changes. ACOG said its new schedule is based on data review and professional consensus, with the aim of reducing confusion in medical settings caused by inconsistent guidance.

The scientific logic of vaccination during pregnancy is familiar: some vaccines protect pregnant people from severe disease, while others provide short-term protection to infants through the transfer of maternal antibodies before they are old enough to be vaccinated. The RSV vaccine is a recent example; reports noted that real-world data studies in the United States showed that vaccination during pregnancy can reduce the risk of RSV hospitalization among infants under three months old. However, evidence from single studies and effectiveness across different populations still need to continue accumulating, and the timing of vaccination, accessibility, and individualized risk assessment should not be simplified into slogans.

The schedule has been endorsed by multiple medical organizations, including the American Academy of Pediatrics and the American Academy of Family Physicians. This cross-specialty support reflects a reality: vaccination during pregnancy does not belong only to obstetrics and gynecology. Pediatrics, family medicine, pharmacists, and nurses all encounter the same families at different points. If different parties give different messages, the first to bear the cost are often pregnant people and caregivers, who must piece together answers on their own from exam rooms, social media, and policy news.

Reports also noted that U.S. uptake of Tdap and RSV vaccines during pregnancy can reach about 70%, but influenza vaccination has fallen to about 30%, and COVID-19 is even lower; gaps also exist across different insurance types and socioeconomic conditions. This is a reminder that guidance itself cannot substitute for access to care. Even if recommendations are clear, whether they are proactively raised during prenatal care, paid for by insurance, and patiently discussed by trusted medical personnel determines whether they are truly put into practice.

ACOG’s move, therefore, is not just another medical chart. It highlights that when the authority of public health institutions is shaped by politics and a crisis of trust, professional societies may be forced to take on a more front-line communication role. For pregnant families, the most practical message remains: vaccine choices should return to personal medical history, gestational age, exposure risk, and physician assessment, rather than having clinical judgment replaced by social media fragments or a single political stance.